247 related articles for article (PubMed ID: 7738624)
1. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
3. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
Osterlind K; Hansen HH; Hansen M; Dombernowsky P; Andersen PK
J Clin Oncol; 1986 Sep; 4(9):1307-13. PubMed ID: 3018182
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Albain KS; Crowley JJ; Livingston RB
Chest; 1991 Jun; 99(6):1425-32. PubMed ID: 2036826
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
7. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
8. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer.
Osterlind K; Hansen HH; Hansen M; Dombernowsky P
J Clin Oncol; 1986 Jul; 4(7):1044-52. PubMed ID: 3014082
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
10. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis.
Hermes A; Waschki B; Gatzemeier U; Reck M
Lung Cancer; 2011 Mar; 71(3):363-6. PubMed ID: 20619477
[TBL] [Abstract][Full Text] [Related]
11. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Bonner JA; Sloan JA; Rowland KM; Klee GG; Kugler JW; Mailliard JA; Wiesenfeld M; Krook JE; Maksymiuk AW; Shaw EG; Marks RS; Perez EA
Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
[TBL] [Abstract][Full Text] [Related]
12. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
[TBL] [Abstract][Full Text] [Related]
13. Practical approaches to the treatment of patients with extensive stage small cell lung cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1994 Aug; 21(4 Suppl 7):3-6. PubMed ID: 7522349
[TBL] [Abstract][Full Text] [Related]
14. Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer.
Shepherd FA; Ginsberg RJ; Evans WK; Feld R; Cooper JD; Ilves R; Todd TR; Pearson FG; Waters PF; Baker MA
J Thorac Cardiovasc Surg; 1983 Oct; 86(4):498-506. PubMed ID: 6312199
[TBL] [Abstract][Full Text] [Related]
15. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC).
Szczepek B; Szymańska D; Decker E; Wasowska H; Slupek A; Rowińska-Zakrzewska E
Lung Cancer; 1994 Jul; 11(1-2):93-104. PubMed ID: 8081708
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic factors for long term survival in patients with small cell lung cancer].
Senkus E; Jassem J; Karnicka-Młodkowska H; Wełnicka-Jaśkiewicz M; Radzikowska E; Broniek A; Krawczyk K; Malak K; Kowal E; Moś-Antkowiak R
Pneumonol Alergol Pol; 1994; 62(5-6):233-8. PubMed ID: 7920272
[TBL] [Abstract][Full Text] [Related]
17. Long-term survivors of small cell carcinoma of the lung.
Vogelsang GB; Abeloff MD; Ettinger DS; Booker SV
Am J Med; 1985 Jul; 79(1):49-56. PubMed ID: 2990209
[TBL] [Abstract][Full Text] [Related]
18. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
19. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
20. Updates in small cell lung cancer treatment.
Walker S
Clin J Oncol Nurs; 2003; 7(5):563-8. PubMed ID: 14603554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
